Hal Sternberg - 04 Jun 2021 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Reporting relationship: Vice President-Research
Issuer ticker: SER
Reported as of: 04 Jun 2021
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jun 2021, 21:36:07 UTC
Source filing: View source filing
Reporting owner signature: /s/Hal Sternberg

Filing notes and source

Key filing fact

Hal Sternberg filed Form 4 for AgeX Therapeutics, Inc. (SER) on 08 Jun 2021.

Key facts

This page summarizes Hal Sternberg's Form 4 filing for AgeX Therapeutics, Inc. (SER).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 08 Jun 2021, 21:36.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

AGE transaction Derivative

Option to Purchase Common Stock

Award

Transaction value: $0
Shares: +5,000
Change %
Price: $0.000000
Shares after: 5,000
Date: 04 Jun 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,000
Exercise price: $1.45
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date.